Log In
Print this Print this

BiovaxID, Lympreva, dasiprotimut-T

  Manage Alerts
Collapse Summary General Information
Company Biovest International Inc.
DescriptionAutologous vaccine containing tumor-specific idiotype proteins from individual patient's lymphoma cells and conjugated to keyhole limpet hemocyanin (KLH)
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today